🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to collect additional safety and efficacy data...
Status
Completed
Location
Chris O'Brien Lifehouse Oncology
Start Date
2016-10-18
Trial ID
NCT03306394
Treatments Being Tested
This phase 1b trial studies the side effects and best dose of TAS-102 when ...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2019-12-11
Trial ID
NCT04104139
This phase I trial investigates the side effects and best dose of talazopar...
Status
Recruiting
Location
Roswell Park Cancer Institute
Start Date
2021-06-08
Trial ID
NCT04511039
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of S 95005 in patient...
Status
Completed
Location
Russian Cancer Research Center n.a. NN Blokhin (RCRC), Clinical Pharmacology and Chemotherapy department
Start Date
2017-03-03
Trial ID
NCT03274882
Treatments Being Tested
This phase II trial studies how well TAS-102, irinotecan, and bevacizumab w...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2019-12-27
Trial ID
NCT04109924
Treatments Being Tested
This phase II trial studies how well trifluridine/tipiracil and irinotecan ...
Status
Completed
Location
Mayo Clinic
Start Date
2019-10-18
Trial ID
NCT04072445
Treatments Being Tested
This phase II trial studies the effect of the combination of ramucirumab an...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2021-06-16
Trial ID
NCT04660760
Treatments Being Tested
This phase II trial studies how well trifluridine/tipiracil and oxaliplatin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2019-12-20
Trial ID
NCT04097028
Treatments Being Tested
The main purpose of this study is to evaluate the progression-free survival...
Status
Completed
Location
Chris O'Brien Lifehouse Oncology
Start Date
2016-04-29
Trial ID
NCT02743221
Treatments Being Tested
The main purpose of this study is to assess the safety and tolerability and...
Status
Completed
Location
Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie
Start Date
2016-05
Trial ID
NCT02848443
Treatments Being Tested